Alector Stock
Alector, Inc.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Arnon Rosenthal
- Employees
- 103
- Market cap
- $205 M
- IPO
- 07/02/2019
Alector, Inc. operates as a clinical-stage biopharmaceutical company, which engages in pioneering of immuno-neurology. It develops portfolio of innate immune system programs, designed to functionally repair genetic mutations and enable the rejuvenated immune cells to counteract emerging brain pathologies. Its…
Alector stock: price history
1D
-3.7%
1W
-11.5%
1M
-4.7%
6M
-28.4%
YTD
+17.9%
1Y
-42.9%
2Y
-64.6%
5Y
-92.1%
10Y
–
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~45% stronger price swings than usual
Ask the agents about Alector
Analyst assessment of Alector
PRICE TARGET LOW
US$1.50
CONSENSUS
US$2.25
MEDIAN
US$2.25
PRICE TARGET HIGH
US$3.00
0
STRONG BUY
9
BUY
3
HOLD
2
SELL
0
STRONG SELL
14
TOTAL · Buy
As of: 15/10/2026
Alector stock metrics
P/E
-1.67
P/B
-20.53
EV/EBITDA
-1.61
RETURN ON EQUITY
230.6%
NET MARGIN
-692.5%
DEBT/EQUITY
-3.29
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
73.8%
FLOAT SHARES
82,357,310
AVG. DAILY VOLUME (30D)
5,178,104
Insider transactions (SEC)
Berkley Neil Lindsay
Wong-Sarad Grace
Rosenthal Arnon
Wong-Sarad Grace
Berkley Neil Lindsay
Institutional holders
Comparable stocks
Frequently asked questions about Alector stock
What does Alector do?
Alector, Inc. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Arnon Rosenthal, the company employs around 103 people.
The IPO was on 07/02/2019; the stock trades on NASDAQ under the ticker ALEC.
What do analysts say about Alector stock?
14 analysts rate the stock, the consensus is Buy (as of 15/10/2026).
The average price target is US$2.25, ranging from US$1.50 to US$3.00, with a median of US$2.25.
This is an external assessment, not a statement by Market Jury.
When does Alector report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 45% stronger than usual.
Does Alector pay a dividend?
No, Alector currently does not pay a dividend.
Which stocks are comparable to Alector?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get Alector stock analyzed?
Clicking "Analyze stock" lets five strategies assess Alector against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.